Recherche
-
Benefit-Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit-Risk Models Applied to Vaccines
(Drug Safety. vol. 43, n° 11, pp. 1089-1104, 2020)Article de revueLibre accès -
Medicine misuse: A systematic review and proposed hierarchical terminology
(British Journal of Clinical Pharmacology, 2020-12-08)Article de revue -
Risk of bradyarrhythmia related to ticagrelor: a systematic review and meta-analysis
(Pharmacological Research. pp. 105089, 2020)Article de revue -
Safety Profile of Drugs for Advanced Melanoma: A Report Based on 2008 to 2018 United States Food and Drug Administration Data
(British Journal of Clinical Pharmacology, 2020-12-08)Article de revue -
Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction
(Journal of the European Academy of Dermatology and Venereology. vol. 34, n° 8, pp. e430-e431, 2020)Article de revue -
Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)
(Drug Safety. vol. 43, n° 11, pp. 1105-1120, 2020)Article de revueLibre accès -
Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit-Risk Models: The Example of Rotavirus Vaccination in France
(Clinical Therapeutics. vol. 42, n° 10, pp. 1983-1991 e2, 2020)Article de revueLibre accès -
DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting database
(Lancet Diabetes and Endocrinology. vol. 8, n° 5, pp. 365-367, 2020)Article de revue -
Severe Adverse Events during Medical and Surgical Treatment of Hip and Knee Prosthetic Joint Infections
(Médecine et Maladies Infectieuses, 2020-10-20)Article de revue -
International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium
(npj Digital Medicine. vol. 3, pp. 109, 2020)Article de revueLibre accès